Molecular structure of Reparixin, CAS Number: 266359-83-5
Reparixin (CAS 266359-83-5)
Alternate Names:
DF 1681Y; (αR)-α-methyl-4-(2-methylpropyl)-N-(methylsulfonyl)-benzeneacetamide
CAS Number:
266359-83-5
Molecular Weight:
283.4
Molecular Formula:
C14H21NO3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Reparixin (CAS 266359-83-5) References
- TRPC6-dependent Ca2+ signaling mediates airway inflammation in response to oxidative stress via ERK pathway. | Chen, Q., et al. 2020. Cell Death Dis. 11: 170. PMID: 32139669
- Contribution of TRPC Channels to Intracellular Ca2 + Dyshomeostasis in Smooth Muscle From mdx Mice. | Lopez, JR., et al. 2020. Front Physiol. 11: 126. PMID: 32153426
- Transient Receptor Potential Cation Channels and Calcium Dyshomeostasis in a Mouse Model Relevant to Malignant Hyperthermia. | Rafael Lopez, J., et al. 2020. Anesthesiology. 133: 364-376. PMID: 32665491
- Memory and Learning Deficits Are Associated With Ca2+ Dyshomeostasis in Normal Aging. | Uryash, A., et al. 2020. Front Aging Neurosci. 12: 224. PMID: 32765253
- TRPC6 participates in the development of blood pressure variability increase in sino-aortic denervated rats. | Wang, Y., et al. 2020. Heart Vessels. 35: 1755-1765. PMID: 32844288
- Reparixin improves survival in critically ill and transplant patients: A meta-analysis. | Piersanti, G., et al. 2023. Eur J Clin Invest. 53: e14015. PMID: 37161521
- CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A. | La Cognata, V., et al. 2023. Cells. 12: PMID: 37508478
- Plasmon-enhanced circular dichroism spectroscopy of chiral drug solutions. | Venturi, M., et al. 2023. J Chem Phys. 159: PMID: 37846957
- Neutrophils as potential therapeutic targets for breast cancer. | Gong, YT., et al. 2023. Pharmacol Res. 198: 106996. PMID: 37972723
- Blocking CXCR1/2 attenuates experimental periodontitis by suppressing neutrophils recruitment. | Huang, Y., et al. 2024. Int Immunopharmacol. 128: 111465. PMID: 38181674
- Interferon-α induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion. | Ma, YT., et al. 2024. Cytokine. 177: 156555. PMID: 38387232
- Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using 90Y-NM600 in combination with androgen deprivation therapy in murine prostate tumors. | Muralidhar, A., et al. 2024. J Immunother Cancer. 12: PMID: 38663936
- Concomitant NAFLD Facilitates Liver Metastases and PD-1-Refractory by Recruiting MDSCs via CXCL5/CXCR2 in Colorectal Cancer. | Yang, Y., et al. 2024. Cell Mol Gastroenterol Hepatol. 18: 101351. PMID: 38724007
Inhibitor of:
β-defensin 46, β-defensin 48, CA X, CCL27b, CCRL2, CKR-1, CXCL13, CXCR-7, EG665186, GROα, GRO1, IL-8, IL-8RA, IL-8RB, IP-10, MIP-2α, RANTES, and Trichohyalin.Activator of:
SARA.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Reparixin, 5 mg | sc-507446 | 5 mg | $76.00 |